Understanding FDA-Approved Labeling and CDC Recommendations for Use of Vaccines

Author:

Meissner H. Cody1,Farizo Karen2,Pratt Douglas2,Pickering Larry K.3,Cohn Amanda C.4

Affiliation:

1. Department of Pediatrics, Tufts Medical Center, Boston, Massachusetts;

2. Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland;

3. Department of Pediatrics, School of Medicine, Emory University, Atlanta, Georgia; and

4. National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

Abstract

Adherence to recommendations for the use of licensed vaccines ensures maximum individual and societal benefits from the national immunization program. The US Food and Drug Administration (FDA) licenses a vaccine once it determines that data submitted by the manufacturer reveal that the vaccine is safe and effective for its intended use. For each US-licensed vaccine, the FDA-approved prescribing information contains detailed information for health care providers to ensure safe and effective use. Centers for Disease Control and Prevention recommendations for the use of a licensed vaccine often are based on additional considerations, such as disease epidemiology, public acceptance, vaccine supply, and cost. Our objective in this article is to explain the reasons for the differences between FDA-approved prescribing information and Centers for Disease Control and Prevention recommendations for vaccine use.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Reference26 articles.

1. Benefits from immunization during the vaccines for children program era - United States, 1994-2013.;Whitney;MMWR Morb Mortal Wkly Rep,2014

2. Immunization policy development in the United States: the role of the Advisory Committee on Immunization Practices.;Smith;Ann Intern Med,2009

3. US Department of Health and Human Services. Charter of the Advisory Committee on Immunization Practices. Available at: https://www.cdc.gov/vaccines/acip/committee/charter.html. Accessed July 12, 2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3